57 year old female with a history of myelofibrosis currently being screened for clinical trial protocol. ABDOMEN:LIVER, BILIARY TRACT: There is a focus of ill defined arterial enhancement in segment 7 of the liver, which does not persist or washout on portal venous or delayed contrast-enhanced sequences. This appears most consistent with a transient hepatic intensity difference.SPLEEN: Marked splenomegaly. The spleen measures approximately 22.9 cm in length. Multiple foci of increased T2 signal abnormality are identified within the spleen, without enhancement which are too small to characterize but may represent hemangiomas or cysts. PANCREAS: No significant abnormality noted.ADRENAL GLANDS: No significant abnormality noted.KIDNEYS, URETERS: Simple cysts are identified in the kidneys bilaterally.RETROPERITONEUM, LYMPH NODES: No significant abnormality noted.BOWEL, MESENTERY: No significant abnormality noted.BONES, SOFT TISSUES: Note is made of multiple foci of increased signal abnormality with peripheral nodular enhancement within the L2 and L3 vertebral bodies, likely representing hemangiomas.OTHER: No significant abnormality noted.
Marked splenomegaly with measurements provided above. 